Novonesis (Novozymes) A/S (NSIS-B) — Cash Flow Reinvestment Rate
Novonesis (Novozymes) A/S (NSIS-B) has a Cash Flow Reinvestment Rate of 0.47x as of March 2026, reinvesting Dkr79.08 Million (capex Dkr79.08 Million ) from operating cash flow of Dkr167.06 Million. Explore Novonesis (Novozymes) A/S (NSIS-B) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Novonesis (Novozymes) A/S Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Novonesis (Novozymes) A/S across 24 annual periods. Also explore Novonesis (Novozymes) A/S total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Novonesis (Novozymes) A/S (2002–2025)
Year-by-year capital reinvestment analysis for Novonesis (Novozymes) A/S. For live market cap and broader valuation context, see Novonesis (Novozymes) A/S (NSIS-B) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | Dkr470.80 Million | Dkr1.22 Billion | Dkr470.80 Million | ▼ -29.7% |
| 2024 | 0.55x | Dkr559.50 Million | Dkr1.02 Billion | Dkr359.80 Million | ▼ -49.2% |
| 2023 | 1.08x | Dkr4.48 Billion | Dkr4.15 Billion | Dkr2.06 Billion | ▼ -22.2% |
| 2022 | 1.39x | Dkr5.56 Billion | Dkr4.01 Billion | Dkr2.89 Billion | ▲ +41.5% |
| 2021 | 0.98x | Dkr3.99 Billion | Dkr4.06 Billion | Dkr1.24 Billion | ▲ +73.5% |
| 2020 | 0.57x | Dkr2.46 Billion | Dkr4.36 Billion | Dkr940.00 Million | ▲ +27.1% |
| 2019 | 0.45x | Dkr1.42 Billion | Dkr3.20 Billion | Dkr862.00 Million | ▼ -39.9% |
| 2018 | 0.74x | Dkr2.72 Billion | Dkr3.68 Billion | Dkr1.33 Billion | ▼ -7.7% |
| 2017 | 0.80x | Dkr3.26 Billion | Dkr4.06 Billion | Dkr1.59 Billion | ▲ +27.1% |
| 2016 | 0.63x | Dkr2.42 Billion | Dkr3.84 Billion | Dkr1.08 Billion | ▲ +117.8% |
| 2015 | 0.29x | Dkr968.00 Million | Dkr3.34 Billion | Dkr968.00 Million | ▲ +86.6% |
| 2014 | 0.16x | Dkr703.00 Million | Dkr4.53 Billion | Dkr703.00 Million | ▼ -47.0% |
| 2013 | 0.29x | Dkr762.00 Million | Dkr2.60 Billion | Dkr762.00 Million | ▼ -31.6% |
| 2012 | 0.43x | Dkr1.18 Billion | Dkr2.76 Billion | Dkr1.18 Billion | ▼ -12.3% |
| 2011 | 0.49x | Dkr1.32 Billion | Dkr2.71 Billion | Dkr1.32 Billion | ▼ -14.5% |
| 2010 | 0.57x | Dkr1.33 Billion | Dkr2.32 Billion | Dkr1.33 Billion | ▲ +1.9% |
| 2009 | 0.56x | Dkr1.02 Billion | Dkr1.82 Billion | Dkr1.02 Billion | ▼ -0.7% |
| 2008 | 0.57x | Dkr959.00 Million | Dkr1.70 Billion | Dkr959.00 Million | ▲ +30.4% |
| 2007 | 0.43x | Dkr743.00 Million | Dkr1.71 Billion | Dkr743.00 Million | ▲ +31.7% |
| 2006 | 0.33x | Dkr505.00 Million | Dkr1.53 Billion | Dkr505.00 Million | ▲ +19.3% |
| 2005 | 0.28x | Dkr366.00 Million | Dkr1.33 Billion | Dkr366.00 Million | ▲ +6.0% |
| 2004 | 0.26x | Dkr335.00 Million | Dkr1.29 Billion | Dkr335.00 Million | ▼ -10.1% |
| 2003 | 0.29x | Dkr398.00 Million | Dkr1.37 Billion | Dkr398.00 Million | ▼ -6.8% |
| 2002 | 0.31x | Dkr367.00 Million | Dkr1.18 Billion | Dkr367.00 Million | — |